Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Administration in Subjects With Family History of Diabetes or Metabolic Syndrome
NCT01181830Phase 4Completed
- Sponsor
- Università degli Studi di Verona
- Start
- Feb 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Pidolic acid in metabolic syndrome, type 2 diabetes mellitus (T2DM), sponsored by Università degli Studi di Verona. Started Feb 2010; status: completed.
02
Drugs
Pidolic acid
03
Conditions
metabolic syndrometype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01181830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01181830.